Xpovio with dexamethasone approved for refractory multiple myeloma
Xpovio (selinexor) tablets have been approved for use in combination with dexamethasone to treat adults with relapsed refractory multiple myeloma, the U.S. Food and Drug Administration announced last week.
Jul 10, 2019
0
0